<![CDATA[Neuropathic plantar diabetic foot ulcers (DFUs) represent a major clinical problem due to their high risk of infection, prolonged morbidity, and frequent progression to amputation. Although standardized offloading remains the cornerstone of management, the role of antimicrobial dressings in improving outcomes compared with non-antimicrobial moist dressings remains controversial. This study aimed to evaluate the efficacy of antimicrobial dressings in enhancing ulcer healing and reducing adverse outcomes in patients with neuropathic plantar DFUs managed under standardized offloading. A systematic review and meta-analysis was conducted following PRISMA guidelines. PubMed, Embase, Cochrane Library, and ClinicalTrials.gov were searched through August 2025. Eligible studies included randomized controlled trials (RCTs) and observational studies comparing antimicrobial dressings (silver, PHMB, honey, iodine) with non-antimicrobial moist dressings. Outcomes assessed were complete healing at 12–16 weeks, amputation rates, and antibiotic use. Data were pooled using random-effects models, and risk of bias was assessed with Cochrane RoB 2.0 and the Newcastle-Ottawa Scale. Fifteen studies (eight RCTs, seven observational) met the inclusion criteria. Pooled results indicated antimicrobial dressings improved healing rates (OR ? 2.1, 95% CI 1.5–3.0), with silver dressings showing modest benefits in infection-related outcomes. However, no consistent effect on amputation rates or antibiotic duration was observed, and the largest RCT (2023) showed no significant benefit over standard moist dressings. Antimicrobial dressings may provide selective benefit in severe or infected ulcers but lack consistent superiority for routine use. These findings suggest that clinicians should adopt a targeted, adjunctive approach while further multicenter RCTs clarify subgroup effects.]]>
Copyrights © 2025
